Brokerages Set Aspen Aerogels, Inc. (NYSE:ASPN) Target Price at $29.70

Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) has been given a consensus rating of “Buy” by the ten brokerages that are covering the stock, Marketbeat reports. Nine analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $29.70.

A number of equities research analysts recently commented on ASPN shares. Benchmark restated a “buy” rating and set a $14.00 price target on shares of Aspen Aerogels in a research report on Thursday, August 8th. Craig Hallum increased their target price on Aspen Aerogels from $33.00 to $38.00 and gave the stock a “buy” rating in a report on Friday, June 14th. TD Cowen lifted their price target on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. HC Wainwright increased their price objective on shares of Aspen Aerogels from $25.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, August 9th. Finally, Piper Sandler boosted their target price on shares of Aspen Aerogels from $30.00 to $36.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 29th.

Read Our Latest Report on ASPN

Insider Transactions at Aspen Aerogels

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 4.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Aspen Aerogels

Large investors have recently bought and sold shares of the company. GSA Capital Partners LLP acquired a new position in shares of Aspen Aerogels in the 1st quarter valued at $1,181,000. Oppenheimer & Co. Inc. bought a new stake in shares of Aspen Aerogels in the first quarter worth about $388,000. AIGH Capital Management LLC increased its holdings in shares of Aspen Aerogels by 3.0% in the fourth quarter. AIGH Capital Management LLC now owns 1,804,484 shares of the construction company’s stock worth $28,475,000 after acquiring an additional 52,462 shares in the last quarter. Comerica Bank acquired a new stake in shares of Aspen Aerogels during the first quarter worth about $1,992,000. Finally, Vanguard Group Inc. lifted its holdings in shares of Aspen Aerogels by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after purchasing an additional 175,906 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Price Performance

Shares of ASPN stock opened at $26.99 on Tuesday. The stock’s fifty day simple moving average is $24.90 and its 200 day simple moving average is $23.36. Aspen Aerogels has a one year low of $6.51 and a one year high of $33.15. The firm has a market cap of $2.06 billion, a price-to-earnings ratio of -61.34 and a beta of 2.16. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82.

Aspen Aerogels (NYSE:ASPNGet Free Report) last issued its earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.05 by $0.16. The company had revenue of $117.80 million for the quarter, compared to the consensus estimate of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The firm’s revenue for the quarter was up 144.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.22) EPS. On average, analysts expect that Aspen Aerogels will post 0.21 earnings per share for the current fiscal year.

About Aspen Aerogels

(Get Free Report

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.